Ad
related to: dfci patient portal
Search results
Results from the Go Local Guru Content Network
Patient care. Dana–Farber/St. Elizabeth's Cancer Center (DF/SEMC) and Dana–Farber/Brigham and Women's Cancer Center (DF/BWCC) are collaborations between Dana–Farber Cancer Institute, St. Elizabeth's Medical Center, and Brigham and Women's Hospital to care for adults with cancer. Dana–Farber provides outpatient services, while inpatient ...
The Jimmy Fund, established in Boston in 1948, is made up of community-based fundraising events and other programs that benefit Dana-Farber Cancer Institute. Since 1948, millions of people have given money to the Jimmy Fund to help save lives and reduce the burden of cancer for patients and families worldwide. [2]
Catherine J. Wu is an American physician-scientist who studies oncology. She is a Professor of Medicine and Chief of Division of Stem Cell Transplantation and Cellular Therapies at the Dana–Farber Cancer Institute. Her research focuses on longitudinal studies of patients with chronic lymphocytic leukemia (CLL).
“We are so pleased that patients in southern Massachusetts and Rhode Island will now have access to the same services and resources provided to Dana-Farber patients in Boston – including many...
The Jimmy Fund (www.JimmyFund.org) solely supports Boston's Dana-Farber Cancer Institute, raising funds for adult and pediatric cancer care and research to improve the chances of survival for ...
Tune in to hear doctors, patients and special guests share stories and support the Jimmy Fund and Dana-Farber Cancer Institute. WEEI Sports Radio Network (93.7 FM), NESN and the Boston Red Sox...
The Jimmy Fund ( www.JimmyFund.org) solely supports Boston's Dana-Farber Cancer Institute, raising funds for adult and pediatric cancer care and research to improve the chances of survival for ...
More than $37 million raised in 13 years for adult and pediatric cancer care and research at Dana-Farber Cancer Institute
Nancy Lin is an American oncologist who works at the Dana-Farber Cancer Institute and is an Associate Professor of Medicine at Harvard Medical School. Her research considers new diagnostic strategies and treatment pathways for HER2 positive breast cancer.
Irene Ghobrial is an American-Egyptian physician who is a professor at the Dana–Farber Cancer Institute and Harvard Medical School, where her research investigates the progression of multiple myeloma.